| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Marcello Deraco | Q43800082 |
| Dario Baratti | Q43800097 | ||
| Shigeki Kusamura | Q59555769 | ||
| Antonio Macrì | Q89037183 | ||
| P2093 | author name string | F Puccio | |
| B Laterza | |||
| S Virzì | |||
| M R Balestra | |||
| E Mingrone | |||
| P S Ravenda | |||
| P433 | issue | 1 | |
| P921 | main subject | ovarian cancer | Q172341 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 4-9 | |
| P577 | publication date | 2010-11-26 | |
| P1433 | published in | European Journal of Surgical Oncology | Q2345728 |
| P1476 | title | Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer | |
| P478 | volume | 37 |
| Q26851836 | Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis |
| Q36160064 | Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details |
| Q38777716 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer |
| Q50794640 | Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case-control study on survival in patients with two year follow-up. |
| Q36128985 | Diagnosis and management of peritoneal metastases from ovarian cancer |
| Q37093435 | Diagnosis and preoperative predictive value of serum HE4 concentrations for optimal debulking in epithelial ovarian cancer |
| Q34540858 | Effects of cyclooxygenase-2 gene silencing on the biological behavior of SKOV3 ovarian cancer cells |
| Q36614305 | Establishment of a new representative model of human ovarian cancer in mice |
| Q34161727 | Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells |
| Q53486371 | Experimental study of antitumour activity and effects on leukocyte count of intraperitoneal administration and hyperthermic intraperitoneal chemoperfusion (HIPEC) with dioxadet in a rat model of ovarian cancer. |
| Q92847043 | Hyperthermic intraperitoneal chemotherapy for ovarian cancer: The heat is on |
| Q35995593 | Impact of post-operative hormone replacement therapy on life quality and prognosis in patients with ovarian malignancy |
| Q36954656 | Knockdown of cathepsin L sensitizes ovarian cancer cells to chemotherapy |
| Q47216330 | Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres |
| Q47809171 | Long-term survival with peritoneal mucinous carcinomatosis from intraductal mucinous papillary pancreatic carcinoma treated with complete cytoreduction and hyperthermic intraperitoneal chemotherapy. |
| Q34213359 | Malignant ascites: pathophysiology and treatment. |
| Q44841536 | Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC). |
| Q38854853 | Overexpression of SOX2 is involved in paclitaxel resistance of ovarian cancer via the PI3K/Akt pathway |
| Q44259666 | Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: a multi-institutional experience |
| Q36953421 | Peritoneal dissemination of hepatoid carcinoma of the ovary treated with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy |
| Q41454278 | Peritoneal metastases of rare carcinomas treated with cytoreductive surgery and HIPEC - A single center case series |
| Q35653290 | Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia |
| Q47787815 | Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study. |
| Q26776510 | The Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian Cancer |
| Q38800078 | The clinical utility of an elevated-risk multivariate index assay score in ovarian cancer patients |
| Q36969635 | The inhibitory effect of ellagic Acid on cell growth of ovarian carcinoma cells |
| Q37114979 | The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy |
| Q38131754 | The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer relapse. |
Search more.